Skip to main content

Table 3 Comparison of demographic and clinical characteristics between transfusion-dependent β-thalassemia patients with and without diabetes mellitus

From: Ocular findings in patients with transfusion-dependent β-thalassemia in southern Iran

Variables

Diabetes mellitus

P-value

Yes = 28

No = 51

Age (year) mean ± SD

30.2 ± 5.8

27.4 ± 5.2

0.031

Hemoglobin (g/dl) mean ± SD

9.9 ± 0.63

9.8 ± 0.69

0.636

Ferritin (ng/ml)

1855 ± 1325

2434 ± 1737

0.129

Sex (male) (%)

28.6

31.4

> 0.999

Splenectomy (yes) (%)

55.6

27.5

0.026

Iron chelation therapy (%)

 Deferoxamine

32.1

7.8

0.027

 Deferasirox

21.4

41.2

 Deferoxamine and Deferiprone

35.7

33.3

 Deferoxamine and Deferasirox

10.7

17.6

Intraocular pressure (mmHg) mean ± SD

16.17 ± 3.5

14.17 ± 3.05

0.010

VA (logMar) (%)

 0–0.1

89.3

100

0.041

  > 0.1

10.7

0

Cataract or lens opacity

10.7

2

0.125

Fundus abnormalities (%)

10.7

9.8

> 0.999

  1. VA visual acuity